SAFE ORTHOPAEDICS SA (ALSAF.PA) Stock Price, Forecast & Analysis
Europe - EPA:ALSAF - FR001400ZU25 - Common Stock
ALSAF.PA Key Statistics, Chart & Performance
The current stock price of ALSAF.PA is 0.0024 EUR. In the past year, price decreased by -99.8%.
ALSAF.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 16.28 | 100.05B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 18.55 | 49.81B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.85 | 23.37B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.96 | 23.51B | ||
| BIM.PA | BIOMERIEUX | 27.64 | 12.63B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 24.65 | 3.77B | ||
| DIA.MI | DIASORIN SPA | 17.11 | 3.32B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.42 | 1.26B | ||
| DRW8.DE | DRAEGERWERK AG | 9.02 | 1.09B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 26.66 | 999.17M | ||
| ELN.MI | EL.EN. SPA | 16.93 | 869.29M | ||
| GVS.MI | GVS SPA | 46.89 | 798.34M |
Related stock screener links
About ALSAF.PA
Company Profile
Safe SA engages in the development, production and commercialization of spinal surgery products. The company is headquartered in Eragny, Ile-De-France. The company went IPO on 2015-02-10. The firm focuses on the development and commercialization of products for use in spinal surgery. The company provides a range of implants and ready to use instrument kits. The firm's product portfolio comprises SteriSpine PS, which is the Pedicle Screw System; and SteriSpine LC, which is the Lumbar Cage System that enables safe implant positioning, as well as access, insertion and placement of the implant. The firm's products are equipped with quick change handle, dual trial and impact removal, among others. The firm mainly uses polyarylamid material, which is a polymar with 50% glass fibers.
Company Info
SAFE ORTHOPAEDICS SA
Parc des Bellevues, Batiment le Californie 5, Allee Rosa Luxemburg
Eragny ILE-DE-FRANCE FR
Employees: 138
Phone: 33134215000
SAFE ORTHOPAEDICS SA / ALSAF.PA FAQ
What does ALSAF do?
Safe SA engages in the development, production and commercialization of spinal surgery products. The company is headquartered in Eragny, Ile-De-France. The company went IPO on 2015-02-10. The firm focuses on the development and commercialization of products for use in spinal surgery. The company provides a range of implants and ready to use instrument kits. The firm's product portfolio comprises SteriSpine PS, which is the Pedicle Screw System; and SteriSpine LC, which is the Lumbar Cage System that enables safe implant positioning, as well as access, insertion and placement of the implant. The firm's products are equipped with quick change handle, dual trial and impact removal, among others. The firm mainly uses polyarylamid material, which is a polymar with 50% glass fibers.
What is the stock price of SAFE ORTHOPAEDICS SA today?
The current stock price of ALSAF.PA is 0.0024 EUR.
What is the dividend status of SAFE ORTHOPAEDICS SA?
ALSAF.PA does not pay a dividend.
How is the ChartMill rating for SAFE ORTHOPAEDICS SA?
ALSAF.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is SAFE ORTHOPAEDICS SA (ALSAF.PA) stock traded?
ALSAF.PA stock is listed on the Euronext Paris - Matif exchange.
What is the Price/Earnings (PE) ratio of SAFE ORTHOPAEDICS SA (ALSAF.PA)?
SAFE ORTHOPAEDICS SA (ALSAF.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-54931.55).
What is the expected growth for ALSAF stock?
The Revenue of SAFE ORTHOPAEDICS SA (ALSAF.PA) is expected to grow by 20.31% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
ALSAF.PA Technical Analysis
ALSAF.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ALSAF.PA. ALSAF.PA may be in some trouble as it scores bad on both profitability and health.
ALSAF.PA Financial Highlights
Over the last trailing twelve months ALSAF.PA reported a non-GAAP Earnings per Share(EPS) of -54931.55. The EPS decreased by -2.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -342.67% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALSAF.PA Forecast & Estimates
For the next year, analysts expect an EPS growth of 41.67% and a revenue growth 20.31% for ALSAF.PA